@Novartis NovartisNovartis posts on X about novartis, $nvs, $novn, india the most. They currently have [-------] followers and [---] posts still getting attention that total [--] engagements in the last [--] hours.
Social category influence stocks 58.7% countries 18.12% travel destinations 1.45% technology brands 0.72%
Social topic influence novartis #25, $nvs 12.32%, $novn 7.25%, india 7.25%, community 4.35%, growth 4.35%, copd 4.35%, heart 3.62%, core 3.62%, health 2.9%
Top accounts mentioned or mentioned by @novartiscom @crackedtrashbag @blackmajikman90 @brentwags12 @zombphoxufl @helelshachar @usfda @saludamerica @bbowler14 @drlovetruth @shanebpimpin420 @asco @ehahematology @sanjanachopra @jeromeadamsmd @cagirl80 @gopalmadan1085 @novartiscancer @xforeverythnig @shobhatuli
Top assets mentioned Novartis AG (NVS)
Top posts by engagements in the last [--] hours
"@czavalas Hi Claudia Zavala Thank you for your enquiry. We recommend you contact our local office in Mexico by phone at +52(55) 5420-8600. For additional contact information visit this page: Kind regards Novartis Community Manager https://www.novartis.com.mx/acerca-de-nosotros/contactanos https://www.novartis.com.mx/acerca-de-nosotros/contactanos"
X Link 2026-02-02T13:20Z 288.3K followers, [--] engagements
"On Wednesday February [--] Novartis will announce its Q4 and Full-Year [----] results. Register to listen here: #NovartisNews $NVS $NOVN #NVSQ425 https://go.novartis.social/45NqoVz https://go.novartis.social/45NqoVz"
X Link 2026-02-03T08:54Z 288.3K followers, [----] engagements
"#NVSQ425 Novartis social media posts on Q4 and Full-Year [----] results contain forward-looking statements. Such forward-looking statements are subject to significant known and unknown risks and uncertainties. Visit our website for more information. #NVSQ425 Novartis social media posts on Q4 and Full-Year [----] contain non-IFRS measures. An explanation of non-IFRS measures is available on our website Novartis quarterly financial results Novartis. $NVS $NOVN https://twitter.com/i/web/status/2018927500336697422 https://twitter.com/i/web/status/2018927500336697422"
X Link 2026-02-04T06:00Z 288.3K followers, [----] engagements
"Heart disease is a major health challenge in Japan. We explore Dr. Mutos vision of a healthcare landscape that seamlessly unites human connection and digital precision to enhance patient care. Learn more: #Novartis #NovartisLive #CVD https://novartis.social/6013q3wzX https://novartis.social/6013q3wzX"
X Link 2025-03-12T12:00Z 288.3K followers, [----] engagements
"This FDA approval is a testament to our commitment to advancing prostate cancer care through research and innovation. Every achievement is driven by our dedication to transforming lives and giving patients what matters most more options. #ReimaginingMedicine Todays regulatory milestone represents a step forward for patients loved ones and providers who have been in need of more options to treat advanced prostate cancer earlier. https://t.co/rnjCkXUxs7 #NovartisUS #ReimaginingMedicine https://t.co/mDUP8115L8 Todays regulatory milestone represents a step forward for patients loved ones and"
X Link 2025-03-28T17:38Z 288.3K followers, [----] engagements
"Marcs journey from unexpected heart attacks to a life-changing diagnosis of a genetic condition has transformed his family's life. Learn more: #Novartis #NovartisLive #CVD https://go.novartis.social/3FReGz3 https://go.novartis.social/3FReGz3"
X Link 2025-04-04T12:00Z 288.3K followers, [----] engagements
"On Tuesday April [--] Novartis will announce its Q1 [----] earnings. Register to listen here: #NovartisNews $NVS $NOVN #NVSQ12025 https://go.novartis.social/4lJVS5h https://go.novartis.social/4lJVS5h"
X Link 2025-04-25T07:30Z 288.3K followers, [----] engagements
"#News: Were excited to announce our upcoming oncology and hematology data that has been recently accepted at @ASCO Annual Meeting and @eha_hematology [----] Congress. #ASCO25 #EHA2025. https://go.novartis.social/3YL3ECf https://go.novartis.social/3YL3ECf"
X Link 2025-05-15T13:50Z 288.3K followers, [----] engagements
"On Thursday July [--] Novartis will announce its Q2 [----] earnings. Register to listen here: #NovartisNews $NVS $NOVN #NVSQ22025 https://go.novartis.social/4nIq029 https://go.novartis.social/4nIq029"
X Link 2025-07-15T12:30Z 288.3K followers, [----] engagements
"#News: @US_FDA approval of our new oral targeted therapy for #ChronicSpontaneousUrticaria brings new hope for patients and underlines our commitment to making bold progress in immunology. https://go.novartis.social/474jV9C #News: The @US_FDA approved a new oral targeted therapy for #ChronicSpontaneousUrticaria (#CSU) offering a new treatment option and renewing hope for this community. Were grateful to all who helped us achieve this milestone. 🔗https://t.co/rD3OoU81wH https://t.co/tItRB649we https://go.novartis.social/474jV9C #News: The @US_FDA approved a new oral targeted therapy for"
X Link 2025-09-30T22:06Z 288.3K followers, [----] engagements
"On Tuesday October [--] Novartis will announce its Q3 [----] earnings. Register to listen here: #NovartisNews $NVS $NOVN #NVSQ32025 https://novartis.social/6010tBbaI https://novartis.social/6010tBbaI"
X Link 2025-10-27T13:15Z 288.3K followers, [----] engagements
"In Q3 [----] Novartis delivered solid sales and core operating income growth with strong pipeline progress. Our key growth drivers performed well and we had important innovation milestone achievements including an FDA approval and positive data readout that has the potential to underpin our growth through [----] and beyond. #NVSQ32025 https://novartis.social/6018t8JRE https://novartis.social/6018t8JRE"
X Link 2025-10-28T11:00Z 288.3K followers, [----] engagements
"#Investors: Novartis delivered high single-digit sales growth achieved 40% core margin and further advanced the pipeline in [----] Press release: IR Webcast: #NVSQ425 https://go.novartis.social/4aaJF4D https://go.novartis.social/3ZTwccA https://go.novartis.social/4aaJF4D https://go.novartis.social/3ZTwccA"
X Link 2026-02-04T13:00Z 288.3K followers, [----] engagements
"@sanjanachopra Dear sanjana Thank you for your enquiry. We recommend you contact our local office in India by phone at +91 [--] [--------] or +91 [--] [----] [----]. For additional contact information visit this Kind regards Novartis Community Manager https://www.novartis.com/in-en/about/india-site-locations https://www.novartis.com/in-en/about/india-site-locations"
X Link 2026-02-09T16:27Z 288.3K followers, [--] engagements
"@JeromeAdamsMD We're happy to hear it Learn more at http://Relaxitsabloodtest.com http://Relaxitsabloodtest.com"
X Link 2026-02-09T16:53Z 288.3K followers, [---] engagements
"@cagirl80 Prostate health is so important and were glad to see that others agree. Learn more at http://Relaxitsabloodtest.com http://Relaxitsabloodtest.com"
X Link 2026-02-09T16:53Z 288.3K followers, [----] engagements
"@debbie3322 Hi @debbie3322 Thank you for your enquiry. We recommend you contact our local office for product related information. You can find contact details of our offices using the location finder on our website: Kind regards Novartis Community Manager https://www.novartis.com/our-company/contact-us/office-locations https://www.novartis.com/our-company/contact-us/office-locations"
X Link 2025-12-31T20:21Z 288.5K followers, [--] engagements
"@gopalmadan1085 Hi @gopalmadan1085 Thank you for your enquiry. We recommend you contact our local office in India by phone at +91 [--] [--------] or +91 [--] [----] [----] for this matter. For additional contact information visit this page: Kind regards Novartis Community https://novartis.com/in-en/about/india-site-locations https://novartis.com/in-en/about/india-site-locations"
X Link 2026-01-05T07:56Z 288.5K followers, [--] engagements
"Dear Hosein Thank you for reaching out about your daughter- we understand your desire to seek treatment urgently for her. We care about every baby in need of treatment and we recognize the burden and emotional toll that spinal muscular atrophy (SMA) has on families. Due to regulatory restraints all inquiries regarding access to treatment with Zolgensma need to be submitted to our Medical Information team directly at medinfoemea.gtx@novartis.com. Thank you once again for reaching out to us. Please know the Novartis Gene Therapies team is working hard to make our gene therapy available to all"
X Link 2026-01-06T14:18Z 288.6K followers, [--] engagements
"@nurika_tw Hi @nurika_tw Thank you for your enquiry. We recommend you contact our local office for this matter. You can find contact details of our offices using the location finder on our website: Kind regards Novartis Community Manager https://www.novartis.com/our-company/contact-us/office-locations https://www.novartis.com/our-company/contact-us/office-locations"
X Link 2026-01-08T08:32Z 288.5K followers, [---] engagements
"Novartis launches Novartis Access a portfolio of affordable meds to treat chronic diseases in the developing world http://t.co/LxlbEu2ST9 http://ow.ly/SBQxd http://ow.ly/SBQxd"
X Link 2015-09-24T10:25Z 291.6K followers, [--] engagements
"Today we announce Vas Narasimhan as new Novartis CEO from Feb [--] [----]. Thank you 👏 Joe Jimenez for your achievements http://bit.ly/2xJeD0W http://bit.ly/2xJeD0W"
X Link 2017-09-04T06:56Z 291.6K followers, [---] engagements
"Breaking: Novartis appoints Elizabeth Barrett as the new CEO of Novartis Oncology welcome Liz @NovartisCancer #NovartisNews http://bit.ly/2EtCELV http://bit.ly/2EtCELV"
X Link 2018-01-11T06:25Z 291.6K followers, [---] engagements
"This #WorldCancerDay was about the value of partnerships to help fight cancer all around the world. #WeCanICan @NovartisCancer @ASCP_Chicago @stompoutcancer @AmericanCancer @Sandoz_Global https://twitter.com/i/moments/961592066420637697 https://twitter.com/i/moments/961592066420637697"
X Link 2018-02-08T14:21Z 288.5K followers, [--] engagements
"BREAKING: Novartis receives European approval for the first treatment specifically designed for #migraine prevention @EMA_News #EMA #Neurology #NovartisNews http://bit.ly/2LB6JRG http://bit.ly/2LB6JRG"
X Link 2018-07-30T20:43Z 292.2K followers, [---] engagements
"Were proud to support the British Lung Foundation as they raise awareness of the benefits of Pulmonary Rehabilitation which can enable patients to exercise and improve their health. #lunguk #BreatheEasyWeek #COPD #asthma #PulmonaryRehab #ERSCongress"
X Link 2018-09-15T17:00Z 298.5K followers, [--] engagements
"Todays #ScienceExplained is on the #eosinophil phenotype in #COPD #ERSCongress"
X Link 2018-09-17T12:00Z 298.3K followers, [--] engagements
"#ers2011 poster session starting now for Novartis #copd data in hall [--] -19"
X Link 2011-09-25T10:50Z 299.2K followers, [--] engagements
"#hidradenitissuppurativa is a debilitating skin condition causing painful abscesses all over the body which can cause irreversible scarring. People wait on average [--] years to get an accurate diagnosis. Lets shorten the time to diagnosis. #HSAwareness"
X Link 2022-06-06T16:39Z 292.6K followers, [---] engagements
"Health is too complex to be addressed by the private or public sectors alone. In the final chapter of a 5-part series hear leaders from both sectors speak to the power of partnerships to bridge the barriers to healthcare. #AccessBarriers #HealthForAll #UNGA78 @DrOdame"
X Link 2023-09-26T11:10Z 301.1K followers, [----] engagements
"#NVSQ323 Novartis tweets on Q3 [----] results contain forward-looking statements. Such forward-looking statements are subject to significant known and unknown risks and uncertainties. Visit our website for more information $NVS $NOVN"
X Link 2023-10-24T05:31Z 300.8K followers, [----] engagements
"Novartis delivered a very strong quarter with double-digit sales and core operating income growth leading to a further upgrade to [----] guidance. #NovartisNews $NVS $NOVN #NVSQ323"
X Link 2023-10-24T05:35Z 296.5K followers, 707.6K engagements
"The stigma surrounding #lungcancer is a real barrier to improving screening conditions and helping patients get the help they need. A focus on spreading awareness and encouraging education can help break down the attitudes toward lung cancer"
X Link 2023-11-01T16:12Z 301.2K followers, [----] engagements
"In drug development confidence in your science makes it possible to choose bold approaches. Read how an unexpected approach to clinical studies showed how thinking big when the science is right can make all the difference"
X Link 2023-11-02T13:00Z 301.3K followers, [----] engagements
"More than [--] million people are diagnosed with #LungCancer yearly and each one has their own unique cancer journey. At Novartis we are committed to improve patient outcomes through innovative medicines. Learn more this #LCAM:"
X Link 2023-11-08T16:01Z 301K followers, [----] engagements
"@AngelaFJohnson1 Thanks for reaching out. We take product safety seriously and would like to know more about your circumstances. Please provide your contact info and social media username to usdrugsafety.operations@novartis.com so we can follow up"
X Link 2023-12-05T21:43Z 301.1K followers, [--] engagements
"@Ashfaq9559 Please contact our local office in Pakistan by phone at +92 [--] [----] [----] or click here:"
X Link 2024-01-02T23:33Z 301K followers, [--] engagements
"@mvmbr Dear Mvm Thank you for your message. Please contact our local office in Brazil for this matter. They can be reached by phone at [----] [---] [----] from Monday Friday 8:30am - 05:00pm (GMT-3) or via email at sic.novartis@novartis.com. Kind regards Novartis Community Manager"
X Link 2024-04-26T08:10Z 300.1K followers, [--] engagements
"@sexy_8901 We saw your tweet. We take product safety seriously and want to know more. Please provide your contact info and social media username to farmaco.novartis@novartis.com so we can follow up"
X Link 2024-05-06T15:00Z 300.1K followers, [---] engagements
"@TheBandicoot7 @TheBandicoot7 Thanks for reaching out. We are sorry to hear about your experience. Please provide your contact info and social media username to complaints.hub_germany@novartis.com so we can follow up"
X Link 2024-05-20T16:29Z 300K followers, [--] engagements
"As pioneers in #RadioligandTherapy (RLT) we have bolstered our manufacturing capacity to meet present and future demand. Its part of our aim to #ReimagineMedicine for people living with advanced cancers. #ASCO24 https://go.novartis.social/4b9pAul https://go.novartis.social/4b9pAul"
X Link 2024-05-29T14:00Z 299.9K followers, [----] engagements
"Partnership and shared expertise can be the key to progress. Every day we value the opportunity to #Reimaginemedicine together with the goal of reaching more cancer patients in need of additional treatment options like #Radioligandtherapy. #ASCO24 #ASCO24 reinforced the collective effort to transform cancer care. As we #Reimaginemedicine together with advocacy groups and healthcare professionals we are exploring ways that collaboration can bring innovation to #Radioligandtherapy. Learn more: https://t.co/Du6FNrZ6r6 https://t.co/Ob5yVJfOoX #ASCO24 reinforced the collective effort to transform"
X Link 2024-06-04T14:24Z 299.9K followers, [----] engagements
"#NVSQ224 Novartis social media posts on Q2 [----] results contain forward-looking statements. Such forward-looking statements are subject to significant known and unknown risks and uncertainties. Visit our website for more information $NVS $NOVN https://go.novartis.social/4cM3saz https://go.novartis.social/4cM3saz"
X Link 2024-07-18T05:36Z 299.7K followers, [----] engagements
"Drivers of Novartis Q2 was discussed @CNBC including: ➡ Progress in cancer pipeline for patients ➡ Advances in delivering innovative high-value medicines ➡ Momentum of recent approvals submissions and investments Full interview here: $NVS $NOVN #NVSQ224 #Investors http://cnb.cx/3Y4rUj7 http://cnb.cx/3Y4rUj7 Novartis CEO Vasant Narasimhan discusses the company's new cancer drug. Watch more here: https://t.co/y9qEsYX1Wv https://t.co/ddybXsGPFl http://cnb.cx/3Y4rUj7 http://cnb.cx/3Y4rUj7 Novartis CEO Vasant Narasimhan discusses the company's new cancer drug. Watch more here:"
X Link 2024-07-19T08:44Z 296.5K followers, [----] engagements
"@Engineer_Sabry @Engineer_Sabry We saw your tweet and would like to know more about your circumstances. Please provide your contact info social media username and location to nps.safetydesk@novartis.com so we can follow up"
X Link 2024-08-05T21:26Z 299.4K followers, [--] engagements
"@SiyamMoses Dear siyam moses Thank you for your enquiry. We recommend you contact our local office for product related information. You can find contact details of our offices using the location finder on our website: Kind regards Novartis Community Manager https://www.novartis.com/our-company/contact-us/office-locations https://www.novartis.com/our-company/contact-us/office-locations"
X Link 2024-09-12T14:05Z 298.4K followers, [--] engagements
"Novartis will issue Q3 [----] results on Tuesday October [--]. We invite #investors to our #earnings webcast to hear updates on our growth and performance. $NVS $NOVN #NVSQ324 https://go.novartis.social/3C07nDv https://go.novartis.social/3C07nDv"
X Link 2024-10-28T10:10Z 297K followers, [----] engagements
"#NVSQ324 Novartis social media posts on Q3 [----] results contain forward-looking statements. Such forward-looking statements are subject to significant known and unknown risks and uncertainties. Visit our website for more information $NVS $NOVN https://go.novartis.social/4f0Zn3C https://go.novartis.social/4f0Zn3C"
X Link 2024-10-29T06:34Z 296.8K followers, [----] engagements
"Novartis delivered strong operational performance and achieved key pipeline milestones in Q3 supporting further upgrade to FY24 guidance. Performance reflects continued strong operational performance with all key growth drivers contributing to momentum. $NVS $NOVN #NVSQ324"
X Link 2024-10-29T09:33Z 296.5K followers, [----] engagements
"@lambournpharma1 @lambournpharma1 Thank you for your enquiry. For product related information we recommend you contact our local office in the United Kingdom by phone at +44 [----] [------] . For additional contact information visit this page: https://www.novartis.co.uk/about-us/contact-us https://www.novartis.co.uk/about-us/contact-us"
X Link 2024-10-29T13:38Z 292.3K followers, [--] engagements
"As a part of our 20+-year commitment to innovation and support in CML we continue to work alongside the clinical and patient communities. #ReimaginingMedicine A milestone like an FDA approval requires teamwork. We are working diligently for people living with chronic myeloid leukemia (#CML). Learn more about what this FDA approval means for CML patients: https://t.co/fylbIKTXPG @LLSusa A milestone like an FDA approval requires teamwork. We are working diligently for people living with chronic myeloid leukemia (#CML). Learn more about what this FDA approval means for CML patients:"
X Link 2024-10-31T14:05Z 296.4K followers, [----] engagements
"Innovation only matters when it reaches those who need it. Today we are honored that Novartis has been ranked first in the [----] Access to Medicine Index. This recognition reinforces our commitment to improving access to breakthrough medicines for people around the world regardless of their location or socio-economic status. While we are grateful for this recognition there is still a large unmet need for medicines some life-changing others potentially life-saving and Novartis is committed to further broaden access to innovation and create sustainable impact. Thank you to our 70000+ associates"
X Link 2024-11-19T13:10Z 296K followers, [----] engagements
"@XforEverythnig Dear @XforEverythnig Thank you for your enquiry. We recommend you contact our local office in China by phone at +86 [--] [----] [----]. For additional contact information visit this page: Kind regards Novartis Community Manager https://www.novartis.com.ph/about-us/contact-us https://www.novartis.com.ph/about-us/contact-us"
X Link 2024-11-22T14:34Z 297.2K followers, [--] engagements
"@XforEverythnig Dear @XforEverythnig We apologize for the confusion. We recommend you contact our local office in Hong Kong by phone at (852) [----] [----]. For additional contact information visit this page: Kind regards Novartis Community Manager https://www.novartis.com/hk-zh/about/contact-us/how-to-contact-us https://www.novartis.com/hk-zh/about/contact-us/how-to-contact-us"
X Link 2024-11-25T10:55Z 297.1K followers, [--] engagements
"@shobhatuli @shobhatuli We saw your tweet and would like to know more about your circumstances. Please provide your contact info and social media username to india.drug_safety@novartis.com so we can follow up"
X Link 2024-12-16T08:41Z 296.9K followers, [---] engagements
"@shobhatuli Dear @shobhatuli Thank you for your message. We have forwarded your message to the appropriate team and our colleagues should contact you shortly. Kind regards Novartis Community Manager"
X Link 2024-12-18T15:16Z 296.7K followers, [---] engagements
"@dharmiknvora Dear @dharmiknvora We recommend you contact our local office in India. They can be reached by phone at +91 [--] [----] [----] or +91 [--] [----] [----]. The local team will follow up with you directly once you contact them. Kind regards Novartis Community Manager"
X Link 2024-12-18T15:18Z 296.7K followers, [--] engagements
"@SandeepH140667 @sandeepH140667 Thank you for your enquiry. For product-related information we recommend you contact our local office in India by phone at +91 [--] [--------] or +91 [--] [----] [----]. For additional contact information visit this https://www.novartis.com/in-en/about/india-site-locations https://www.novartis.com/in-en/about/india-site-locations"
X Link 2025-01-06T15:49Z 296.5K followers, [--] engagements
"@Artannes @Artannes Thank you for your enquiry. For product related information we recommend you contact our local office in the United Kingdom by phone at +44 [----] [------] . For additional contact information visit this page: https://www.novartis.co.uk/about-us/contact-us https://www.novartis.co.uk/about-us/contact-us"
X Link 2025-01-08T08:59Z 296.6K followers, [--] engagements
"@LisaMad15680550 Dear Lisa Maddox Thank you for your enquiry. We recommend you contact our local office for product related information. You can find contact details of our offices using the location finder on our website: Kind regards Novartis Community Manager https://www.novartis.com/our-company/contact-us/office-locations https://www.novartis.com/our-company/contact-us/office-locations"
X Link 2025-01-13T11:05Z 296.1K followers, [--] engagements
"@RodrigoAFiguero @RodrigoAFiguero Thank you for your enquiry. For product related information we recommend you contact our local office in Chile by phone at +56 [--] [----] [----]. For additional contact information visit this page: Kind regards Novartis Community Manager https://www.novartis.com/about/locations https://www.novartis.com/about/locations"
X Link 2025-01-13T14:39Z 296.1K followers, [--] engagements
"@LisaMad15680550 @LisaMad15680550 We saw your tweet and would like to know more about your circumstances. Please provide your contact info and social media username to usdrugsafety.operations@novartis.com so we can follow up"
X Link 2025-01-14T15:59Z 296.5K followers, [--] engagements
"@calamityjane001 @calamityjane001 Thank you for reaching out. For help regarding any product-specific questions we encourage you to contact our Customer Interaction Center by visiting or by calling 1-888-669-6682 so we can be of more assistance. https://www.novartis.com/us-en/contact-select https://www.novartis.com/us-en/contact-select"
X Link 2025-01-21T10:17Z 296.2K followers, [--] engagements
"On Friday January [--] Novartis will announce its Q4 and Full-Year [----] results. Register to listen here: #NovartisNews $NVS $NOVN #NVSQ424 https://go.novartis.social/4hA0oAi https://go.novartis.social/4hA0oAi"
X Link 2025-01-30T08:26Z 295.6K followers, [----] engagements
"#NVSQ424 Novartis social media posts on Q4 and Full-Year [----] results contain forward-looking statements. Such forward-looking statements are subject to significant known and unknown risks and uncertainties. Visit our website for more information: $NVS $NOVN https://go.novartis.social/3EvgOM4 https://go.novartis.social/3EvgOM4 https://go.novartis.social/3EvgOM4 https://go.novartis.social/3EvgOM4"
X Link 2025-01-31T06:42Z 295.6K followers, [----] engagements
"#Investors: In our first full-year as a pure-play innovative medicines company Novartis delivered stand-out FY [----] performance delivering strong sales growth with margin expansion and achieving several key innovation milestones. #NVSQ424 https://go.novartis.social/3PXGcgg https://go.novartis.social/3PXGcgg"
X Link 2025-01-31T13:28Z 295.4K followers, [----] engagements
"@THERobertL We're so glad this resonates with you Discover more at http://YourAttentionPlease.com http://YourAttentionPlease.com"
X Link 2025-02-10T14:50Z 295.6K followers, [--] engagements
"@avmena Breast health is so important and were glad to see that others agree. Learn more at http://YourAttentionPlease.com http://YourAttentionPlease.com"
X Link 2025-02-10T14:50Z 295.6K followers, [--] engagements
"@pappyschwartz We're so glad this resonates with you Discover more at http://YourAttentionPlease.com http://YourAttentionPlease.com"
X Link 2025-02-10T14:53Z 295.6K followers, [--] engagements
"@CharlaiCooper Thank you for being part of the conversation Explore more at http://YourAttentionPlease.com http://YourAttentionPlease.com"
X Link 2025-02-10T14:53Z 295.6K followers, [--] engagements
"@JohnDigles We're so glad this resonates with you Discover more at http://YourAttentionPlease.com http://YourAttentionPlease.com"
X Link 2025-02-10T15:00Z 295.6K followers, [---] engagements
"@DonnieBrownSkin We're happy to hear it Learn more at http://YourAttentionPlease.com http://YourAttentionPlease.com"
X Link 2025-02-10T15:00Z 295.6K followers, [--] engagements
"@RocioInOC Thank you for being part of the conversation Explore more at http://YourAttentionPlease.com http://YourAttentionPlease.com"
X Link 2025-02-10T15:01Z 295.6K followers, [--] engagements
"@MosheIsaacian We're so glad this resonates with you Discover more at http://YourAttentionPlease.com http://YourAttentionPlease.com"
X Link 2025-02-11T08:55Z 295.6K followers, [--] engagements
"@star9girl9 Dear Dalia Thank you for reaching out. We encourage you to contact our Customer Interaction Center by visiting or by calling 1-888-669-6682 so we can be of more assistance. Kind regards Novartis Community Manager https://www.novartis.com/us-en/contact-select https://www.novartis.com/us-en/contact-select"
X Link 2025-02-13T10:40Z 295.6K followers, [--] engagements
"Cardiovascular diseases claim nearly [--] million lives annually. At Novartis we're committed to changing this. Through innovative therapies and partnerships we're tackling this public health challenge head-on. Learn more: #Novartis #NovartisLive #CVD https://novartis.social/6019qH8gz https://novartis.social/6019qH8gz"
X Link 2025-03-07T13:30Z 295.1K followers, [----] engagements
"@cfsandoval @cfsandoval We saw your comment. We take product safety seriously and want to know more. Please provide your contact info social media username and location to nps.safetydesk@novartis.com so we can follow up"
X Link 2025-03-14T13:59Z 295.2K followers, [--] engagements
"@mpamadhave4045 @mpamadhave4045 We recommend you contact our sponsoring and donations team at sponsoring.donations@novartis.com. Additionally you could reach out to our local offices. Contact details can be found using the location finder on our website: https://www.novartis.com/our-company/contact-us/office-locations https://www.novartis.com/our-company/contact-us/office-locations"
X Link 2025-03-17T13:06Z 295.2K followers, [--] engagements
"@sara5890ch Dear Sara Ch Thank you for your message. We recommend you contact our local office near you for more information. For information on how to contact Novartis country offices visit this page: Kind regards Novartis Community Manager https://www.novartis.com/our-company/contact-us/office-locations https://www.novartis.com/our-company/contact-us/office-locations"
X Link 2025-03-17T13:19Z 295.1K followers, [--] engagements
"@devnek @devnek Thank you for your message. We are committed to highly ethical business practices and do not tolerate any misconduct of our associates. To process your enquiry please contact our SpeakUp office by using our reporting tool i-Sight Portal here https://nvs.i-sight.com/portal https://nvs.i-sight.com/portal"
X Link 2025-03-25T14:41Z 295K followers, [--] engagements
"@rickyflair25 @rickyflair25 Thank you for reaching out. While we cant discuss specific patient circumstances for privacy reasons we recommend you contact our EMEA Medical Information team at medinfoemea.gtx@novartis.com to learn about all applicable support & resources available"
X Link 2025-04-04T12:28Z 294.8K followers, [--] engagements
"@PahujaAkshit Dear akshitpahuja Thank you for your enquiry. We recommend you contact our local office in India by phone at +91 [--] [--------] or +91 [--] [----] [----]. For additional contact information visit this page: Kind regards Novartis Community Manager https://www.novartis.com/in-en/about/india-site-locations https://www.novartis.com/in-en/about/india-site-locations"
X Link 2025-04-22T13:24Z 294.3K followers, [--] engagements
"@blessedAyesha @blessedAyesha Thank you for your enquiry. For product related information we recommend you contact our local office in Pakistan by phone at +922132313386 +922132313397-98. For additional contact information visit this page: https://www.novartis.com/pk-en/about/pakistan-office-info https://www.novartis.com/pk-en/about/pakistan-office-info"
X Link 2025-04-24T14:41Z 294.3K followers, [--] engagements
"Dear Ruchika Udainiya Thank you for your message. We are committed to highly ethical business practices and do not tolerate any misconduct of our associates. To process your enquiry please contact our SpeakUp office by using our reporting tool i-Sight Portal here Kind regards Novartis Community Manager https://nvs.i-sight.com/portal https://nvs.i-sight.com/portal"
X Link 2025-04-24T14:41Z 294.3K followers, [--] engagements
"Hi @unfinishedasta Please follow & DM us with your contact info so we can follow up with you directly. Alternatively you can contact our local office near you for this matter. For information on how to contact Novartis country offices visit this page: Kind regards Novartis Community Manager https://www.novartis.com/our-company/contact-us/office-locations https://www.novartis.com/our-company/contact-us/office-locations https://www.novartis.com/our-company/contact-us/office-locations https://www.novartis.com/our-company/contact-us/office-locations"
X Link 2025-05-09T07:31Z 293.7K followers, [--] engagements
"Dear @ReadyToRelax Thank you for reaching out. For help regarding any product-specific questions we encourage you to contact our Customer Interaction Center by visiting or by calling 1-888-669-6682 so we can be of more assistance. Kind regards Novartis Community Manager https://www.novartis.com/us-en/contact-select https://www.novartis.com/us-en/contact-select https://www.novartis.com/us-en/contact-select https://www.novartis.com/us-en/contact-select"
X Link 2025-05-09T07:33Z 292.7K followers, [--] engagements
"@cechacek1 @cechacek1 Thank you for your message. We recommend you contact our local office near you for more information. For information on how to contact Novartis country offices visit this page: https://www.novartis.com/our-company/contact-us/office-locations https://www.novartis.com/our-company/contact-us/office-locations"
X Link 2025-05-16T08:08Z 292.7K followers, [--] engagements
"@ReadyToRelax Hi @ReadyToRelax Thank you for your enquiry were sorry to hear this. Please follow & DM us with your contact info so a member of our team can follow up with you directly"
X Link 2025-05-19T17:28Z 292.7K followers, [--] engagements
"Dear Sarang Shahani Thank you for your enquiry. For product-related information we recommend you contact our local office in India by phone at +91 [--] [--------] or +91 [--] [----] [----]. For additional contact information visit this page: Kind regards Novartis Community Manager https://www.novartis.com/in-en/about/india-site-locations https://www.novartis.com/in-en/about/india-site-locations https://www.novartis.com/in-en/about/india-site-locations https://www.novartis.com/in-en/about/india-site-locations"
X Link 2025-06-04T07:32Z 292.6K followers, [--] engagements
"Dear @SatyaVed9 Thank you for reaching out about your baby- we understand your desire to seek treatment urgently for him. We care about every baby in need of treatment and we recognize the burden and emotional toll that spinal muscular atrophy (SMA) has on families. Due to regulatory restraints all inquiries regarding access to treatment with Zolgensma need to be submitted to our Medical Information team directly at medinfoapac.gtx@novartis.com. Thank you once again for reaching out to us. Please know the Novartis Gene Therapies team is working hard to make our gene therapy available to all"
X Link 2025-06-06T08:44Z 292.6K followers, [--] engagements
"@shyampsdp Thank you for your interest in Novartis @shyampsdp. To learn about current job openings at Novartis please check out http://bit.ly/2AhoUWv http://bit.ly/2AhoUWv"
X Link 2025-06-17T07:51Z 292.6K followers, [--] engagements
"@vilaschandra Thank you for your enquiry. For product-related information we recommend you contact our local office in India by phone at +91 [--] [--------] or +91 [--] [----] [----]. For additional contact information visit this page: Kind regards Novartis Community Manager https://www.novartis.com/in-en/about/india-site-locations https://www.novartis.com/in-en/about/india-site-locations"
X Link 2025-06-24T12:16Z 292.6K followers, [--] engagements
"Dear akshitpahuja Thank you for your enquiry. For product-related information we recommend you contact our local office in India by phone at +91 [--] [--------] or +91 [--] [----] [----]. For additional contact information visit this Kind regards Novartis Community Manager https://www.novartis.com/in-en/about/india-site-locations https://www.novartis.com/in-en/about/india-site-locations https://www.novartis.com/in-en/about/india-site-locations https://www.novartis.com/in-en/about/india-site-locations"
X Link 2025-07-04T12:03Z 292.6K followers, [--] engagements
"@Weather_West @Weather_West We saw your tweet and would like to know more about your circumstances. Please provide your contact info and social media username to usdrugsafety.operations@novartis.com so we can follow up"
X Link 2025-07-11T14:31Z 292.6K followers, [---] engagements
"@ffjoshmom Hi ffjoshmom Thank you for your message. We recommend you contact our local office near you for more information. For information on how to contact Novartis country offices visit this page: Kind regards Novartis Community Manager https://www.novartis.com/our-company/contact-us/office-locations https://www.novartis.com/our-company/contact-us/office-locations"
X Link 2025-07-14T07:38Z 292.6K followers, [--] engagements
"@alanspeaksout @alanspeaksout We saw your tweet. We take product safety seriously and want to know more. Please provide your contact info and social media username to usdrugsafety.operations@novartis.com so we can follow up"
X Link 2025-07-16T01:43Z 292.6K followers, [--] engagements
"Hi Sardar Atif Ayub Bhatti Thank you for your enquiry. For product related information we recommend you contact our local office in Pakistan by phone at +922132313386 +922132313397-98. For additional contact information visit this page: Kind regards Novartis Community Manager https://www.novartis.com/pk-en/about/pakistan-office-info https://www.novartis.com/pk-en/about/pakistan-office-info https://www.novartis.com/pk-en/about/pakistan-office-info https://www.novartis.com/pk-en/about/pakistan-office-info"
X Link 2025-07-22T15:31Z 292.6K followers, [--] engagements
"@talisettyprasad Dear @talisettyprasad Thank you for your enquiry. We recommend you contact our local office in India by phone at +91 [--] [--------] or +91 [--] [----] [----]. For additional contact information visit this Kind regards Novartis Community Manager https://www.novartis.com/in-en/about/india-site-locations https://www.novartis.com/in-en/about/india-site-locations"
X Link 2025-08-05T14:45Z 292.5K followers, [--] engagements
"Dear HeKeIsDa Thank you for your enquiry. For product related information we recommend you contact our local office in Colombia by phone at [------------] / +57 [--] [---] [----]. For additional contact information visit this page: Kind regards Novartis Community Manager https://www.novartis.com/co-es/sobre-novartis/contactanos https://www.novartis.com/co-es/sobre-novartis/contactanos https://www.novartis.com/co-es/sobre-novartis/contactanos https://www.novartis.com/co-es/sobre-novartis/contactanos"
X Link 2025-08-13T09:46Z 292.5K followers, [--] engagements
"@AndreiMishra Dear @AndreiMishra Thank you for your enquiry. We recommend you contact our local office in Saudi Arabia by phone at +966 [--] [---] [----] or +966 [--] [---] [----]. For additional contact information visit this page: Kind regards Novartis Community Manager https://www.novartis.com/about/locationsfield_location_business_unit_target_id=All&field_location_country_target_id=4811 https://www.novartis.com/about/locationsfield_location_business_unit_target_id=All&field_location_country_target_id=4811"
X Link 2025-08-13T09:48Z 292.5K followers, [--] engagements
"@yama141502 @yama141502 Thank you for your interest in working with Novartis. For information on how to contact Novartis for business partnerships please visit: https://www.novartis.com/our-company/novartis-partnering https://www.novartis.com/our-company/novartis-partnering"
X Link 2025-08-18T14:15Z 292.5K followers, [--] engagements
"@amelieolaiz Dear Amlie Olaiz Thank you for your enquiry. For product related information we recommend you contact our local office in Mexico by phone at +52(55) 5420-8600. For additional contact information visit this page: Kind regards Novartis Community Manager https://www.novartis.com.mx/acerca-de-nosotros/contactanos https://www.novartis.com.mx/acerca-de-nosotros/contactanos"
X Link 2025-08-21T09:23Z 292.5K followers, [--] engagements
"@PNDash1 @PNDash1 Thank you for your enquiry. We recommend you contact our local office for this matter. You can find contact details of our offices using the location finder on our website: https://www.novartis.com/our-company/contact-us/office-locations https://www.novartis.com/our-company/contact-us/office-locations"
X Link 2025-09-15T13:34Z 292.4K followers, [--] engagements
"@shingarey_sept Hi Shreesh Shingarey Thank you for your message. We recommend you contact our local office near you. For information on how to contact Novartis country offices visit this page: Kind regards Novartis Community Manager https://www.novartis.com/our-company/contact-us/office-locations https://www.novartis.com/our-company/contact-us/office-locations"
X Link 2025-09-17T15:06Z 292.2K followers, [--] engagements
"@organichyck Hi @organichyck Thanks for getting in touch. We understand your concern and want to make sure you get the right support. Please reach out to our US Customer Interaction Center at 1-888-669-6682 or visit and someone will be happy to help. https://www.novartis.com/us-en/patients-and-caregivers/patient-assistance/novartis-patient-support https://www.novartis.com/us-en/patients-and-caregivers/patient-assistance/novartis-patient-support"
X Link 2025-10-02T08:31Z 292.2K followers, [--] engagements
"Dear @ramsaydav Thank you for your message. We recommend you consult your physician who is best positioned to advise you on your treatment. For additional information you could reach out to our local office. You can find contact details of our offices using the location finder on our website: Kind regards Novartis Community Manager https://www.novartis.com/our-company/contact-us/office-locations https://www.novartis.com/our-company/contact-us/office-locations"
X Link 2025-10-09T09:23Z 292.2K followers, [--] engagements
"Dear Ashutosh Dey Thank you for your enquiry. For product-related information we recommend you contact our local office in India by phone at +91 [--] [--------] or +91 [--] [----] [----]. For additional contact information visit this The local team will follow up with you directly once you contact them. Kind regards Novartis Community Manager https://www.novartis.com/in-en/about/india-site-locations https://www.novartis.com/in-en/about/india-site-locations https://www.novartis.com/in-en/about/india-site-locations https://www.novartis.com/in-en/about/india-site-locations"
X Link 2025-10-13T08:14Z 292.2K followers, [--] engagements
"#DidYouKnow four of the most common causes of #blindness globally are #cataract #glaucoma #DME and #AMD http://t.co/F7KCnIShFD http://bit.ly/144pt1w http://bit.ly/144pt1w"
X Link 2014-11-22T11:01Z 298.4K followers, [--] engagements
"A new 3D view of airways finds a target for potential #asthma and #COPD therapies http://t.co/Wewzr0mbp7 http://t.co/dfIXhn5jHl http://bit.ly/1aeGjxi http://bit.ly/1aeGjxi"
X Link 2015-04-10T14:59Z 298.4K followers, [--] engagements
"US Only: #COPD affects nearly 27M people in the US thats more than 8x the population of #ATS2015 host city Denver. http://t.co/CUKl0BcubO http://bit.ly/1K4gHTr http://bit.ly/1K4gHTr"
X Link 2015-05-16T15:00Z 298.4K followers, [--] engagements
"Results from EXPEDITION #COPD clinical trial programs unveiled now at #ATS2015 http://t.co/Ad2F988YWF http://bit.ly/1EXSAyd http://bit.ly/1EXSAyd"
X Link 2015-05-20T15:56Z 298.4K followers, [--] engagements
"Missed the #COPD news See the results from the EXPEDITION & GEM #COPD studies: http://t.co/RjG5uXIkhS #ATS2015 http://bit.ly/1Bcd99y http://bit.ly/1Bcd99y"
X Link 2015-05-21T18:01Z 298.4K followers, [--] engagements
"BREAKING: Rwanda the 3rd country to sign a memorandum of understanding w/ #NovartisAccess after Kenya & Ethiopia: http://bit.ly/2gu8EEu http://bit.ly/2gu8EEu"
X Link 2016-11-29T20:30Z 298.4K followers, [--] engagements
"Most of #psoriasis patients suffer from plaque psoriasis & 90% develop nail or palms and soles (palmoplantar) psoriasis #G2C2017"
X Link 2017-11-28T13:00Z 299.2K followers, [--] engagements
"70% of #COPD pts live with CV disease. New data on heart function in @LancetRespirMed #NovartisNews http://bit.ly/2FmyZkG http://bit.ly/2FmyZkG"
X Link 2018-02-22T08:16Z 298.4K followers, [--] engagements
"Find more #inspiringwomen talk about their #COPD and new ways to improve their lives on our website #PressforProgress"
X Link 2018-03-14T14:30Z 298.2K followers, [--] engagements
"#Investors: Novartis delivered high single-digit sales growth achieved 40% core margin and further advanced the pipeline in [----] Press release: IR Webcast: #NVSQ425 https://go.novartis.social/4aaJF4D https://go.novartis.social/3ZTwccA https://go.novartis.social/4aaJF4D https://go.novartis.social/3ZTwccA"
X Link 2026-02-04T13:00Z 288.3K followers, [----] engagements
"#NVSQ425 Novartis social media posts on Q4 and Full-Year [----] results contain forward-looking statements. Such forward-looking statements are subject to significant known and unknown risks and uncertainties. Visit our website for more information. #NVSQ425 Novartis social media posts on Q4 and Full-Year [----] contain non-IFRS measures. An explanation of non-IFRS measures is available on our website Novartis quarterly financial results Novartis. $NVS $NOVN https://twitter.com/i/web/status/2018927500336697422 https://twitter.com/i/web/status/2018927500336697422"
X Link 2026-02-04T06:00Z 288.3K followers, [----] engagements
"On Wednesday February [--] Novartis will announce its Q4 and Full-Year [----] results. Register to listen here: #NovartisNews $NVS $NOVN #NVSQ425 https://go.novartis.social/45NqoVz https://go.novartis.social/45NqoVz"
X Link 2026-02-03T08:54Z 288.3K followers, [----] engagements
"Delighted to announce the extension of the @WHO@Novartis memorandum of understanding continuing the provision of free multidrug therapy for #leprosy treatment and expanding support to include funding for single-dose rifampicin for post-exposure prophylaxis. For [--] years WHO and Novartis have partnered to interrupt the transmission and eliminate leprosy disease. In [----] #Jordan became the first country verified and acknowledged by WHO for elimination of leprosy showing when science equity and partnership are aligned disease elimination becomes within reach. Thank you Novartis for your"
X Link 2026-01-21T19:54Z 2M followers, [----] engagements
"#News: Today marks a milestone in our $23 billion US expansion plan as we announce the opening of a state-of-the-art radioligand therapy (RLT) manufacturing facility in Carlsbad CA. 🔗 https://go.novartis.social/47LONem https://go.novartis.social/47LONem"
X Link 2025-11-10T15:37Z [----] followers, [----] engagements
"In Q3 [----] Novartis delivered solid sales and core operating income growth with strong pipeline progress. Our key growth drivers performed well and we had important innovation milestone achievements including an FDA approval and positive data readout that has the potential to underpin our growth through [----] and beyond. #NVSQ32025 https://novartis.social/6018t8JRE https://novartis.social/6018t8JRE"
X Link 2025-10-28T11:00Z 288.3K followers, [----] engagements
"On Tuesday October [--] Novartis will announce its Q3 [----] earnings. Register to listen here: #NovartisNews $NVS $NOVN #NVSQ32025 https://novartis.social/6010tBbaI https://novartis.social/6010tBbaI"
X Link 2025-10-27T13:15Z 288.3K followers, [----] engagements
"#News: @US_FDA approval of our new oral targeted therapy for #ChronicSpontaneousUrticaria brings new hope for patients and underlines our commitment to making bold progress in immunology. https://go.novartis.social/474jV9C #News: The @US_FDA approved a new oral targeted therapy for #ChronicSpontaneousUrticaria (#CSU) offering a new treatment option and renewing hope for this community. Were grateful to all who helped us achieve this milestone. 🔗https://t.co/rD3OoU81wH https://t.co/tItRB649we https://go.novartis.social/474jV9C #News: The @US_FDA approved a new oral targeted therapy for"
X Link 2025-09-30T22:06Z 288.3K followers, [----] engagements
"#News: The @US_FDA approved a new oral targeted therapy for #ChronicSpontaneousUrticaria (#CSU) offering a new treatment option and renewing hope for this community. Were grateful to all who helped us achieve this milestone. http://bit.ly/46y1Hxa http://bit.ly/46y1Hxa"
X Link 2025-09-30T21:54Z [----] followers, [----] engagements
"This #WorldHeartDay were celebrating The FIT Stop event in Madrid. Inspired by the analogy of a cars engine & the human heart we invited citizens to partake in fun and educational activities to encourage awareness of cardiovascular health. Lets protect our hearts & help others do the same. Together we can make a difference. #Cardiology #HeartHealth #NoHeartLostTooSoon #WorldHeartDay2025"
X Link 2025-09-29T07:05Z 288.3K followers, [----] engagements
"September is a month of reflection and momentum in #hematology a time to recognize those affected by chronic blood cancers and disorders and to advocate for the progress still needed so patients can live life well. 🎥 Here's how were driving change:"
X Link 2025-09-01T12:00Z 288.3K followers, [----] engagements
"Madrid is calling and weve arrived for #ESCCongress The Novartis team is on the ground and ready to engage in bold conversations share cutting-edge science and explore the future of cardiovascular care. Visit our full event page #Cardiology #HeartHealth #NoHeartLostTooSoon https://novartis.social/6013sbuw7 https://novartis.social/6013sbuw7"
X Link 2025-08-29T15:05Z 288.3K followers, [----] engagements
"Dominic Brittain our Senior Global Program Head CRM Development is looking ahead to what promises to be an inspiring weekend at @escardio #ESCCongress [----] where were presenting new data in cardiovascular disease"
X Link 2025-08-20T07:00Z 288.3K followers, [----] engagements
"Novartis delivered a strong Q2 [--] with double-digit sales growth and core margin expansion. We advanced our pipeline and key launches are accelerating. We upgraded our FY [--] core operating income guidance and remain confident in our mid- to long-term growth outlook. #NVSQ22025 https://go.novartis.social/4lGw9dO https://go.novartis.social/4lGw9dO"
X Link 2025-07-17T10:00Z 288.3K followers, [----] engagements
"On Thursday July [--] Novartis will announce its Q2 [----] earnings. Register to listen here: #NovartisNews $NVS $NOVN #NVSQ22025 https://go.novartis.social/4nIq029 https://go.novartis.social/4nIq029"
X Link 2025-07-15T12:30Z 288.3K followers, [----] engagements
"#News: Were excited to announce our upcoming oncology and hematology data that has been recently accepted at @ASCO Annual Meeting and @eha_hematology [----] Congress. #ASCO25 #EHA2025. https://go.novartis.social/3YL3ECf https://go.novartis.social/3YL3ECf"
X Link 2025-05-15T13:50Z 288.3K followers, [----] engagements
"Novartis had a strong Q1 [----] with double-digit sales growth robust margin expansion and significant pipeline progress including [--] new product approvals. We upgraded our full-year guidance and remain focused on advancing our pipeline and achieving our growth outlook. #NVSQ12025 https://go.novartis.social/3RBDQ7B https://go.novartis.social/3RBDQ7B"
X Link 2025-04-29T12:00Z 288.3K followers, [----] engagements
"On Tuesday April [--] Novartis will announce its Q1 [----] earnings. Register to listen here: #NovartisNews $NVS $NOVN #NVSQ12025 https://go.novartis.social/4lJVS5h https://go.novartis.social/4lJVS5h"
X Link 2025-04-25T07:30Z 288.3K followers, [----] engagements
"Marcs journey from unexpected heart attacks to a life-changing diagnosis of a genetic condition has transformed his family's life. Learn more: #Novartis #NovartisLive #CVD https://go.novartis.social/3FReGz3 https://go.novartis.social/3FReGz3"
X Link 2025-04-04T12:00Z 288.3K followers, [----] engagements
"This FDA approval is a testament to our commitment to advancing prostate cancer care through research and innovation. Every achievement is driven by our dedication to transforming lives and giving patients what matters most more options. #ReimaginingMedicine Todays regulatory milestone represents a step forward for patients loved ones and providers who have been in need of more options to treat advanced prostate cancer earlier. https://t.co/rnjCkXUxs7 #NovartisUS #ReimaginingMedicine https://t.co/mDUP8115L8 Todays regulatory milestone represents a step forward for patients loved ones and"
X Link 2025-03-28T17:38Z 288.3K followers, [----] engagements
"Todays regulatory milestone represents a step forward for patients loved ones and providers who have been in need of more options to treat advanced prostate cancer earlier. #NovartisUS #ReimaginingMedicine https://go.novartis.social/4jdekBs https://go.novartis.social/4jdekBs"
X Link 2025-03-28T17:19Z [----] followers, [----] engagements
"Heart disease is a major health challenge in Japan. We explore Dr. Mutos vision of a healthcare landscape that seamlessly unites human connection and digital precision to enhance patient care. Learn more: #Novartis #NovartisLive #CVD https://novartis.social/6013q3wzX https://novartis.social/6013q3wzX"
X Link 2025-03-12T12:00Z 288.3K followers, [----] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing